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One hundred and eleven isolates of methicillin-resistant Staphylococcus aureus recovered from patients at the
Olin E. Teague Veterans Center from March 1983 to April 1987 were as susceptible to lysis by lysostaphin as
methicillin-susceptible S. aureus controls were.
The staphylolytic enzyme lysostaphin was discovered by
Schindler and Schuhardt (9) and was shown to lyse staph-
ylococci but to be inactive against all other organisms (3, 6,
9). The basis for the specificity of lysostaphin appears to be
its peptidolytic action on pentaglycine cross-linkages, which
are peculiar to the cell walls of staphylococci (4). Schleifer
and Kloos (10) proposed the use of lysostaphin susceptibility
for differentiation of staphylococci from micrococci. Baker
(1) found that most Staphylococcus aureus isolates tested
were lysed by lysostaphin but that lysis of coagulase-nega-
tive staphylococci was inconsistent. Zygmunt et al. (15)
found that over 400 strains of multiply resistant methicillin-
susceptible S. aureus (MSSA) were lysèd by lysostaphin.
Conversely, cross-resistance to seven antibiotics did not
arise in laboratory-selected lysostaphin-resistant mutants.
MSSA seems to be inherently susceptible to lysostaphin, but
the literature is inconclusive on lysostaphin susceptibility of
methicillin-resistant S. aureus (MRSA). Sabath et al. (8)
reported diminished lysis but Seligman (11) reported en-
hanced lysis of MRSA by lysostaphin. Zygmunt et al. (14)
reported that five strains initially isolated as MRSA were
susceptible to lysostaphin but, on repeat testing, were found
to have lost their methicillin resistance. No more than a
dozen isolates were tested in any study, so no systematic
study of the susceptibility of MRSA to lysostaphin has been
reported. We report testing a large number of clinical iso-
lates of MRSA collected over a 4-year period to ascertain
whether methicillin resistance affects the credibility of lyso-
staphin as a taxonomic criterion.
A total of 111 clinical isolates of MRSA were collected
from March 1983 to April 1987. The 111 isolates were single
isolates from 99 patients and 2 isolates each from 6 patients.
MRSA isolates from the same patient were different as
follows: 3 sets were collected from different sites; 1 set was
from the same site but a month apart; 1 set had different
antibiograms; 1 set had no difference. Antimicrobial suscep-
tibility patterns were available for 94 of the 111 isolates. The
organisms segregated into 15 resistance patterns, with 33%
falling into the most common antibiogram type, 30% falling
into another type, and 37% scattered among the other 13
antibiogram types. While some testing of the same strain
probably occurred, the diversity of antibiograms indicates
that the 111 MRSA isolates represent more than a single
endemic strain persisting for 4 years in our hospital. Methi-
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cillin resistance was determined by the disk diffusion proce-
dure of Boyce (2) and corroborated by AutoMicrobic System
Gram-Positive Susceptibility MIC (Vitek Systems, Inc.,
Hazelwood, Mo.) results. Methicillin resistance was recon-
firmed for 12 random isolates (oxacillin MIC, >8 ,ug/ml) by
Sceptor Gram-Positive MIC panels (Johnston Laboratories,
Inc., Towson, Md.). Organisms were maintained at -70°C in
Trypticase soy broth (BBL Microbiology Systems, Cockeys-
ville, Md.) plus 20% glycerol in 2-ml vials. Vials were
thawed, and organisms were streaked to 5% sheep blood
agar plates (BBL). S. aureus ATCC 25923 was the methicil-
lin-susceptible (MSSA) control organism. Lyophilized lyso-
staphin (Mead Johnson, Evansville, Ind.) was diluted with
sterile distilled water to a concentration of 1,000 1ig/ml.
Rehydrated lysostaphin was stored at -20°C until use. The
24-h growth from sheep blood agar plates was suspended to
produce a heavy suspension in 5.5 ml of phosphate-buffered
saline (pH 7.3). Suspended organisms (2.5 ml) were dis-
pensed into two tubes (12 by 75 mm). Lysostaphin (25 Fil)
was pipetted into test suspensions, and 25 ,ul of phosphate-
buffered saline was added to the control tubes. The final
concentration of lysostaphin was 10 ,ug/ml. Optical density
(OD) of test and control suspensions was determined by
using a Coleman Junior spectrophotometer (The Perkin-
Elmer Corp., Norwalk, Conn.) at 520 nm. OD was deter-
mined after 0, 10, 20, 30, 40, and 60 min of incubation in a
37°C water bath.
The average percent reduction in turbidity for 111 isolates
ofMRSA is represented by the closed-square curve in Fig. 1.
No appreciable autolysis was shown by MRSA isolates or
MSSA control suspensions. Comparison of curves indicates
that every MRSA isolate was lysed by lysostaphin, and the
average rate of lysis indicated MRSA isolates (closed
squares) to be as sensitive to lysis as were MSSA controls
(open circles). The shaded area shows the range of reduction
in turbidity seen in lysis tests. The width of the range oflysis
curve could be due to variation in strain susceptibility or the
turbidity of initial suspensions. The effect of initial turbidity
on the rate of lysis of MRSA by 10 p.g of lysostaphin per ml
is shown in Fig. 2. Heavy suspensions showed slower
clearing, as would be expected with enzyme saturation.
Heavy suspensions did continue to clear with time. The
heaviest suspension showed the slowest rate but reached
93% reduction of turbidity in 90 min. Initial turbidities
ranged from 0.361 to 1.067 OD units. Optimal turbidity
appeared to be greater than 0.4 but less than 0.9 OD units

























O 10 20 50 60 70
Time (Minutes)
FIG. 1. Lysis of MRSA with 10 ,ug of lysostaphin per ml. M.
Average lysis of 111 MRSA isolates; O, average lysis of MSSA
ATCC 25923; W, average of 111 MRSA autolysis controls; *,
average MSSA autolysis control. Shaded area shows the range of
lysis curves for 111 MRSA isolates.
standard no. 3 or no. 4, which read 0.621 and 0.787 OD units,
respectively. Some strain variation in susceptibility oc-
curred, but all test suspensions became practically clear by 1
h. Interpretations of susceptibility could have easily been
done with the unaided eye.
Intrinsic or high-level resistance to methicillin is probably
due to a low-affinity penicillin-binding protein (PBP) 2'
which is found in addition to the four PBPs possessed by
MSSA (5). Sabath et al. (7, 8) reported decreased lysis of
MRSA with lysostaphin and suggested that MRSA had
altered cell walls. Stark et al. (12) noted slower in vitro lysis
of MRSA than of MSSA but reported uniform susceptibility
of MRSA to lysostaphin. On the other hand, Seligman (11)
found increased susceptibility of MRSA to lysostaphin in 5
of 7 strains shown to have exaggerated autolytic activity.
The physiological function of PBPs involves peptidoglycan
synthesis, but despite the acquisition of PBP 2', no unusual
cell wall polymers have been found in MRSA (13). Wilkinson
et al. (13) reported that the peptidoglycan of some MRSA
strains had slightly diminished glycine levels compared with
that of normal S. aureius strains. Regardless of the content of
glycine in the cell wall, susceptibility of MRSA to lysostaph-
in suggests the same biophysical importance of pentaglycine
bridging in MRSA and MSSA. The similarity of lysis curves
for MRSA and MSSA suggests comparable susceptibility.
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FIG. 2. Effect of initial turbidity on the rate of lysis of MRSA by
10 Atg of lysostaphin per ml. O, Initial OD > 0.3 < 0.6, n = 27; O,
initial OD > 0.6 < 0.7, n = 35; A, initial OD > 0.7 < 0.8, n = 31;
*, initial OD > 0.8 < 0.9, n = 12; M, initial OD > 0.9, n = 6.
criterion even in strains which have acquired methicillin
resistance.
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